Journal articles on the topic 'BRCA genes'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'BRCA genes.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Zhang, Yinuo. "BRCA1, BRCA2 and primary ovarian insufficiency." E3S Web of Conferences 165 (2020): 05009. http://dx.doi.org/10.1051/e3sconf/202016505009.
Full textMcNevin, Ciara S., Karen Cadoo, Anne-Marie Baird, Pierre Murchan, Orla Sheils, Ray McDermott, and Stephen Finn. "Pathogenic BRCA Variants as Biomarkers for Risk in Prostate Cancer." Cancers 13, no. 22 (November 14, 2021): 5697. http://dx.doi.org/10.3390/cancers13225697.
Full textSchwartz, Zachary Phillip, Mae Zakhour, Andrew John Li, Christine S. Walsh, Bj Rimel, Monica Alvarado, Scott E. Lentz, and Ilana Cass. "Comparison of risk-reducing surgery in women with BRCA and non-BRCA ovarian cancer susceptibility genes." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 1547. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1547.
Full textSahnane, Nora, Ileana Carnevali, Giorgio Formenti, Jvan Casarin, Sofia Facchi, Raffaella Bombelli, Eleonora Di Lauro, et al. "BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor." International Journal of Molecular Sciences 21, no. 24 (December 19, 2020): 9708. http://dx.doi.org/10.3390/ijms21249708.
Full textIncorvaia, Lorena, Chiara Brando, Alessandro Perez, Marco Bono, Daniela Cancelliere, Alessia Pivetti, Nadia Barraco, et al. "Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): 10592. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10592.
Full textЖурман, В. Н., Н. Г. Плехова, and М. Л. Филипенко. "Mutational Status of BRCA Genes in Ovarian Cancer." Евразийский онкологический журнал, no. 2 (August 16, 2022): 118–25. http://dx.doi.org/10.34883/pi.2022.10.2.016.
Full textMcNevin, Ciara S., Karen Cadoo, Anne-Marie Baird, Stephen P. Finn, and Ray McDermott. "PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures." Cancers 14, no. 19 (September 29, 2022): 4751. http://dx.doi.org/10.3390/cancers14194751.
Full textMeireles, Pedro Antunes, Catarina Bexiga, Sofia Fragoso, Sidónia Santos, Teresa Duarte, and Fátima Vaz. "Abstract PO3-08-03: Comparing prognosis for BRCA1, BRCA2 and non-BRCA breast cancer." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO3–08–03—PO3–08–03. http://dx.doi.org/10.1158/1538-7445.sabcs23-po3-08-03.
Full textBrankovic-Magic, Mirjana, Jelena Dobricic, Radmila Jankovic, Irene Konstantopoulou, Drakoulis Yannoukakos, and Sinisa Radulovic. "Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?" Archive of Oncology 14, no. 3-4 (2006): 131–35. http://dx.doi.org/10.2298/aoo0604131b.
Full textFoglietta, Jennifer, Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola, Maria Sole Reda, Antonella Al-Refaie, Francesca Romana Tofanetti, et al. "Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study." Genes 11, no. 8 (August 12, 2020): 925. http://dx.doi.org/10.3390/genes11080925.
Full textBracci, Ciarapica, Zabaleta, Tartaglione, Pirozzi, Giuliani, Piva, et al. "BRCA1 and BRCA2 Gene Expression: Diurnal Variability and Influence of Shift Work." Cancers 11, no. 8 (August 9, 2019): 1146. http://dx.doi.org/10.3390/cancers11081146.
Full textGuo, Li yuan, Tiantian Han, Didi Guo, Juan Ma, Yaping Zhao, Fanfeng Bu, Siqi Chen, Wanglong Deng, and Ran Ding. "Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 10584. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10584.
Full textDias Nunes, Joana, Isabelle Demeestere, and Melody Devos. "BRCA Mutations and Fertility Preservation." International Journal of Molecular Sciences 25, no. 1 (December 22, 2023): 204. http://dx.doi.org/10.3390/ijms25010204.
Full textSzentmartoni, Gyongyver, Dorottya Mühl, Renata Csanda, Attila Marcell Szasz, Zoltan Herold, and Magdolna Dank. "Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors." Biomedicines 12, no. 3 (March 6, 2024): 593. http://dx.doi.org/10.3390/biomedicines12030593.
Full textBarbero, Giovanna, Roberta Zuntini, Pamela Magini, Laura Desiderio, Michela Bonaguro, Anna Myriam Perrone, Daniela Rubino, et al. "Characterization of BRCA Deficiency in Ovarian Cancer." Cancers 15, no. 5 (February 28, 2023): 1530. http://dx.doi.org/10.3390/cancers15051530.
Full textWoodward, Emma R., and Stefan Meyer. "Fanconi Anaemia, Childhood Cancer and the BRCA Genes." Genes 12, no. 10 (September 27, 2021): 1520. http://dx.doi.org/10.3390/genes12101520.
Full textOktay, Kutluk, Ja Yeon Kim, David Barad, and Samir N. Babayev. "Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks." Journal of Clinical Oncology 28, no. 2 (January 10, 2010): 240–44. http://dx.doi.org/10.1200/jco.2009.24.2057.
Full textLee, Yen-Chien, Yen-Ling Lee, and Chung-Yi Li. "BRCA Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies." Medicina 57, no. 9 (August 30, 2021): 905. http://dx.doi.org/10.3390/medicina57090905.
Full textSekine, Masayuki, Koji Nishino, and Takayuki Enomoto. "Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location." Genes 12, no. 7 (July 8, 2021): 1050. http://dx.doi.org/10.3390/genes12071050.
Full textSpizzo, Gilbert, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony Frank Shields, Sukeshi Patel Arora, et al. "Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI)." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 4085. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4085.
Full textSeeber, Andreas, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony Frank Shields, Mohamed E. Salem, et al. "Association of BRCA-mutant pancreatic cancer with high tumor mutational burden (TMB) and higher PD-L1 expression." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 4133. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4133.
Full textSeeber, Andreas, Kai Zimmer, Florian Kocher, Alberto Puccini, Joanne Xiu, Chadi Nabhan, Andrew Elliott, et al. "Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma." ESMO Open 5, no. 6 (November 2020): e000942. http://dx.doi.org/10.1136/esmoopen-2020-000942.
Full textRichters, Lisa Katharina, Philip C. Schouten, Stefan Kommoss, Jan Hauke, Alexander Burges, Dimo Dietrich, Ahmed El-Balat, et al. "BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 5546. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.5546.
Full textShweash, Muhannad, Saddam Jumaa Naseer, Maisam Khider Al-anii, and Thulfiqar Fawwaz Mutar. "A MOLECULAR-BASED APPROACH TO INVESTIGATE BREAST CANCER 1 AND BREAST CANCER 2 STATUS IN OVARIAN CANCER AMONG IRAQI WOMEN." Asian Journal of Pharmaceutical and Clinical Research 11, no. 7 (July 7, 2018): 199. http://dx.doi.org/10.22159/ajpcr.2018.v11i7.25217.
Full textHou, Minmin, Li Sun, Xiuzhang Yu, Pengyao Du, Chuang Liu, Fanfan Meng, Yaxuan Zhang, and Ling Li. "The landscape of BRCA1 and BRCA2 alterations in Chinese ovarian cancer patients." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): e17565-e17565. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e17565.
Full textDe Bono, Johann S., Nobuaki Matsubara, Nicolas Penel, Niven Mehra, Michael Paul Kolinsky, Emmanuelle Bompas, Susan Feyerabend, et al. "Exploratory gene-by-gene analysis of olaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): PROfound." Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021): 126. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.126.
Full textAtchley, Deann P., Constance T. Albarracin, Adriana Lopez, Vicente Valero, Christopher I. Amos, Ana Maria Gonzalez-Angulo, Gabriel N. Hortobagyi, and Banu K. Arun. "Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer." Journal of Clinical Oncology 26, no. 26 (September 10, 2008): 4282–88. http://dx.doi.org/10.1200/jco.2008.16.6231.
Full textNovikova, EI, EA Kudinova, VK Bozhenko, and VA Solodkiy. "Characteristics of BRCA-associated breast cancer in the population of the Russian Federation." Features of HIV and SARS-CoV-2 coinfection in a pandemic, no. 2021(1) (February 2021): 24–29. http://dx.doi.org/10.24075/brsmu.2021.006.
Full textAntunes Meireles, Pedro, Sofia Fragoso, Teresa Duarte, Sidónia Santos, Catarina Bexiga, Priscila Nejo, Ana Luís, et al. "Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer." Cancers 15, no. 23 (December 3, 2023): 5699. http://dx.doi.org/10.3390/cancers15235699.
Full textIncorvaia, Lorena, Alessia Fiorino, Anna Paola Carreca, Stefania Gori, Saverio Cinieri, Giuseppe Curigliano, Chiara Brando, et al. "Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD)." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 10519. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10519.
Full textAbida, Wassim, Alan Haruo Bryce, Nicholas J. Vogelzang, Robert J. Amato, Ivor John Percent, Jeremy David Shapiro, Raymond S. McDermott, et al. "Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 5031. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5031.
Full textReisinger, Raquel, Sergiusz Wesolowski, Umang Swami, Pedro C. Barata, Edgar Javier Hernandez, Roberto Nussenzveig, Gordon Lemmon, et al. "Differences in the genomic landscape of advanced prostate cancer (aPC) patients (pts) with BRCA1 versus BRCA2 mutations as detected by machine learning analysis of the comprehensive genomic profile (CGP) of cell-free DNA (cfDNA)." Journal of Clinical Oncology 39, no. 6_suppl (February 20, 2021): 162. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.162.
Full textBurciaga-Flores, Carlos H., Diana C. Perez-Ibave, Maria L. Garza-Rodriguez, Oscar Vidal-Gutierrez, Cynthia M. Villarreal-Garza, and Dione Aguilar y. Mendez. "Abstract 3947: Non-BRCA variants in hereditary breast and ovarian cancer patients in the Northern Mexico population." Cancer Research 84, no. 6_Supplement (March 22, 2024): 3947. http://dx.doi.org/10.1158/1538-7445.am2024-3947.
Full textAllain, Dawn C., Kevin Sweet, and Doreen M. Agnese. "Management Options after Prophylactic Surgeries in Women with BRCA Mutations: A Review." Cancer Control 14, no. 4 (October 2007): 330–37. http://dx.doi.org/10.1177/107327480701400403.
Full textOshi, Masanori, Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada, Kazutaka Narui, et al. "Establishment of a novel BRCAness score that predicts response to PARP inhibitors." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 549. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.549.
Full textTabaliuk, Y. O., L. A. Rybchenko, B. T. Klimuk, and S. V. Klymenko. "Screening for mutations in BRCA1 and BRCA2 genes and related perspectives for the healthcare system." Visnik ukrains'kogo tovaristva genetikiv i selekcioneriv 18, no. 1-2 (January 29, 2021): 44–57. http://dx.doi.org/10.7124/visnyk.utgis.18.1-2.1354.
Full textGirolimetti, Giulia, Anna Myriam Perrone, Donatella Santini, Elena Barbieri, Flora Guerra, Simona Ferrari, Claudio Zamagni, Pierandrea De Iaco, Giuseppe Gasparre, and Daniela Turchetti. "BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management." BioMed Research International 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/787143.
Full textChoi, Doo Ho, Min Hyuk Lee, Allen E. Bale, Darryl Carter, and Bruce G. Haffty. "Incidence of BRCA1 and BRCA2 Mutations in Young Korean Breast Cancer Patients." Journal of Clinical Oncology 22, no. 9 (May 1, 2004): 1638–45. http://dx.doi.org/10.1200/jco.2004.04.179.
Full textPanda, Anshuman, Mark N. Stein, Gregory Riedlinger, Gyan Bhanot, and Shridar Ganesan. "Role for immune checkpoint blockade in BRCA2-mutant prostate cancer." Journal of Clinical Oncology 37, no. 8_suppl (March 10, 2019): 59. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.59.
Full textSecondino, Angela, Flavio Starnone, Iolanda Veneruso, Maria Di Tella, Serena Conato, Carmine De Angelis, Sabino De Placido, and Valeria D’Argenio. "Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment." Genes 13, no. 4 (April 13, 2022): 682. http://dx.doi.org/10.3390/genes13040682.
Full textOktay, K., J. Kim, D. Barad, N. Gleicher, and S. Babayev. "Association of BRCA1 mutations with diminished ovarian reserve: A common genetic mechanism for breast/ovarian cancer, and infertility?" Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 11039. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11039.
Full textWesolowski, R., A. G. Shealy, J. Tao, and H. C. Moore. "Differential outcomes in patients treated with endocrine therapy for early or locally advanced breast cancer based on BRCA mutation status." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e22065-e22065. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e22065.
Full textGoindani, Piryanka, Ghulam Haider, Ammara ., Faiza Mahar, Ahra Sami, Perah Manzoor, and Monika Bai. "Positivity of BRCA 1 & 2 Mutations in Ovarian Cancer." Pakistan Journal of Medical and Health Sciences 17, no. 5 (May 23, 2024): 681–83. http://dx.doi.org/10.53350/pjmhs2023175681.
Full textTian, Jiangfang, Du He, Zhixi Huang, Bole Tian, and Dan Cao. "Main driver genes and BRCA mutation in Chinese patients with pancreatic adenocarcinoma." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e15741-e15741. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15741.
Full textCaleca, Laura, Mara Colombo, Thomas van Overeem Hansen, Conxi Lázaro, Siranoush Manoukian, Michael T. Parsons, Amanda B. Spurdle, and Paolo Radice. "GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes." Cancers 11, no. 2 (January 28, 2019): 151. http://dx.doi.org/10.3390/cancers11020151.
Full textMadariaga, Ainhoa, Stephanie Lheureux, and Amit Oza. "Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations." Cancers 11, no. 3 (March 23, 2019): 416. http://dx.doi.org/10.3390/cancers11030416.
Full textBayrakli, Fatih, Bekir Akgun, Burcak Soylemez, Metin Kaplan, and Mustafa Gurelik. "Variation in the BRCA2 gene in a child with medulloblastoma and a family history of breast cancer." Journal of Neurosurgery: Pediatrics 8, no. 5 (November 2011): 476–78. http://dx.doi.org/10.3171/2011.8.peds11210.
Full textKapoor, Nimmi S., Lisa D. Curcio, Carlee A. Blakemore, Amy K. Bremner, Rachel E. McFarland, John G. West, and Kimberly C. Banks. "Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer." Journal of Clinical Oncology 33, no. 28_suppl (October 1, 2015): 16. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.16.
Full textAbdrakhmanova, Aliya, Nazgul Omarbayeva, Dilyara Kaidarova, Gulnur Zhunussova, Saltanat Abdikerim, Saule Yessenkulova, Aizhan Jakipbayeva, Zhanna Chingissova, and Leila Djansugurova. "Next generation sequencing analysis of key genes in breast cancer patients from Kazakh population." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13548-e13548. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13548.
Full textWang, Xinfeng, Tomi Jun, Nan Sun, Jie He, and Kuan-lin Huang. "Abstract 5692: Tissue specificity of chromosome aneuploidy correlates with BRCA-associated cancer risk." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5692. http://dx.doi.org/10.1158/1538-7445.am2022-5692.
Full text